Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasets

The 5-year overall survival (OS) of pancreatic ductal adenocarcinoma (PDAC) is only 10%, partly owing to the lack of reliable diagnostic and prognostic biomarkers. The raw gene-cell matrix for single-cell RNA-seq (scRNA-seq) analysis was downloaded from the GSA database. We drew cell atlas for PDAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kai, Liu, Xinxin, Liu, Weikang, Wang, Feng, Tian, Xiaodong, Yang, Yinmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Bioinformatics Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122644/
https://www.ncbi.nlm.nih.gov/pubmed/34957503
http://dx.doi.org/10.1093/hmg/ddab343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122644/
https://www.ncbi.nlm.nih.gov/pubmed/34957503
http://dx.doi.org/10.1093/hmg/ddab343

Ejemplares similares